Dimensional Fund Advisors LP Ultragenyx Pharmaceutical Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 7,748 shares of RARE stock, worth $346,723. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,748

Previous 9,975 22.33%

Holding current value

$346,723

Previous $409,000 5.13%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$40.21 - $59.36 $89,547 - $132,194	-2,227 Reduced 22.33%	7,748 $430,000
Q2 2024 Aug 09, 2024	SELL	$37.42 - $51.61 $1,571 - $2,167	-42 Reduced 0.42%	9,975 $409,000
Q1 2024 May 10, 2024	SELL	$43.02 - $53.69 $1.49 Million - $1.86 Million	-34,623 Reduced 77.56%	10,017 $467,000
Q4 2023 Feb 07, 2024	SELL	$31.73 - $49.19 $317,680 - $492,490	-10,012 Reduced 18.32%	44,640 $2.13 Million
Q3 2023 Nov 09, 2023	SELL	$34.92 - $46.66 $1.43 Million - $1.91 Million	-40,993 Reduced 42.86%	54,652 $1.95 Million
Q2 2023 Aug 09, 2023	SELL	$37.35 - $52.15 $215,472 - $300,853	-5,769 Reduced 5.69%	95,645 $4.41 Million
Q1 2023 May 12, 2023	SELL	$36.99 - $48.71 $4.15 Million - $5.46 Million	-112,119 Reduced 52.51%	101,414 $4.07 Million
Q4 2022 Feb 09, 2023	SELL	$33.72 - $46.33 $3,945 - $5,420	-117 Reduced 0.05%	213,533 $9.89 Million
Q3 2022 Nov 10, 2022	SELL	$39.96 - $66.14 $5.5 Million - $9.1 Million	-137,602 Reduced 39.17%	213,650 $8.85 Million
Q2 2022 Aug 12, 2022	SELL	$45.8 - $85.4 $5.16 Million - $9.63 Million	-112,744 Reduced 24.3%	351,252 $21 Million
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $8.83 Million - $12 Million	141,945 Added 44.08%	463,996 $33.7 Million
Q4 2021 Feb 09, 2022	BUY	$73.71 - $87.86 $7.06 Million - $8.42 Million	95,795 Added 42.34%	322,051 $27.1 Million
Q3 2021 Nov 12, 2021	BUY	$77.92 - $102.4 $4.37 Million - $5.74 Million	56,065 Added 32.94%	226,256 $20.4 Million
Q2 2021 Aug 12, 2021	BUY	$92.19 - $115.71 $325,799 - $408,919	3,534 Added 2.12%	170,191 $16.2 Million
Q1 2021 May 14, 2021	SELL	$106.9 - $167.73 $19.2 Million - $30.2 Million	-179,884 Reduced 51.91%	166,657 $19 Million
Q4 2020 Feb 25, 2021	BUY	$84.4 - $177.39 $29.2 Million - $61.5 Million	346,541 New	346,541 $48 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Ultragenyx Pharmaceutical Inc. Transaction History